Position in DSGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$4,594,776
+$1,800,279 QoQ
Shares Held
431,840
+45.0% QoQ
Ownership
0.691%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 71%
Shared 19%
None 10%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. DSGN ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in DSGN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,594,776 | 431,840 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $2,794,497 | 297,921 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,107,020 | 279,817 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,056,031 | 313,363 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,114,002 | 288,602 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,328,183 | 215,265 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $722,855 | 134,360 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $271,191 | 80,953 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $148,523 | 36,855 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $110,895 | 41,848 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $127,709 | 54,115 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $375,699 | 59,635 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $441,316 | 76,485 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,581,268 | 154,120 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,154,738 | 128,872 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $394,016 | 28,144 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||